1 | you with the best | | | | | | | 2 | 0.68% |
2 | so that we can | | | | | | | 2 | 0.68% |
3 | clearcanvas home support endoflife | | | | | | | 1 | 0.34% |
4 | privacy overview this website | | | | | | | 1 | 0.34% |
5 | out more or adjust | | | | | | | 1 | 0.34% |
6 | more or adjust your | | | | | | | 1 | 0.34% |
7 | settings accept clearcanvas privacy | | | | | | | 1 | 0.34% |
8 | accept clearcanvas privacy overview | | | | | | | 1 | 0.34% |
9 | clearcanvas privacy overview strictly | | | | | | | 1 | 0.34% |
10 | privacy overview strictly necessary | | | | | | | 1 | 0.34% |
11 | cookies powered by gdpr | | | | | | | 1 | 0.34% |
12 | powered by gdpr plugin | | | | | | | 1 | 0.34% |
13 | by gdpr plugin privacy | | | | | | | 1 | 0.34% |
14 | gdpr plugin privacy overview | | | | | | | 1 | 0.34% |
15 | plugin privacy overview this | | | | | | | 1 | 0.34% |
16 | overview this website uses | | | | | | | 1 | 0.34% |
17 | experience find out more | | | | | | | 1 | 0.34% |
18 | cookies so that we | | | | | | | 1 | 0.34% |
19 | that we can provide | | | | | | | 1 | 0.34% |
20 | we can provide you | | | | | | | 1 | 0.34% |
21 | can provide you with | | | | | | | 1 | 0.34% |
22 | with the best user | | | | | | | 1 | 0.34% |
23 | the best user experience | | | | | | | 1 | 0.34% |
24 | possible cookie information is | | | | | | | 1 | 0.34% |
25 | cookie information is stored | | | | | | | 1 | 0.34% |
26 | information is stored in | | | | | | | 1 | 0.34% |
27 | is stored in your | | | | | | | 1 | 0.34% |
28 | stored in your browser | | | | | | | 1 | 0.34% |
29 | in your browser and | | | | | | | 1 | 0.34% |
30 | find out more or | | | | | | | 1 | 0.34% |
31 | browsing experience find out | | | | | | | 1 | 0.34% |
32 | functions such as recognising | | | | | | | 1 | 0.34% |
33 | home support endoflife faq | | | | | | | 1 | 0.34% |
34 | brightmatter bridge are trademarks | | | | | | | 1 | 0.34% |
35 | bridge are trademarks of | | | | | | | 1 | 0.34% |
36 | are trademarks of synaptive | | | | | | | 1 | 0.34% |
37 | medical inc or its | | | | | | | 1 | 0.34% |
38 | inc or its subsidiaries | | | | | | | 1 | 0.34% |
39 | or its subsidiaries patents | | | | | | | 1 | 0.34% |
40 | its subsidiaries patents pending | | | | | | | 1 | 0.34% |